Published in Cancer Weekly, December 6th, 2005
But now, scientists are combining a novel kind of "nanocomplex" consisting of a microscopic, lipid-based liposome and an antibody along with gene therapy in an approach they hope will both detect and target metastatic cancer cells for destruction.
Esther H. Chang, PhD, at Georgetown University Medical Center's Lombardi Comprehensive Cancer Center in Washington, DC, and her co-workers have created a liposome nanoparticle roughly one millionth of an inch across with antibodies peppering the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.